Discovery and Potential Applications of MIR30D as A Drug Target and Biomarker
Discovery and Potential Applications of MIR30D as A Drug Target and Biomarker
MIR30D (hsa-miR-30d-3p) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR30D is a microRNA (miRNA) that is expressed in a variety of tissues and has been shown to play a role in regulating gene expression. The discovery of MIR30D as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases.
An Overview of MicroRNA Technology
MicroRNAs are short non-coding RNAs that are typically between 20 and 60 nucleotides in length. They are produced by RNA polymerase II and are degraded and expressed in the cytoplasm. MicroRNAs have been shown to play a critical role in post-transcriptional gene regulation, cell growth, and apoptosis. They are also involved in various signaling pathways and are potential targets for drugs.
MIR30D: A Potential Drug Target and Biomarker
MIR30D is a non-coding RNA molecule that has been shown to be involved in the regulation of gene expression. It is expressed in various tissues, including brain, heart, and cancer. MIR30D has been shown to play a role in the regulation of cell proliferation, apoptosis, and angiogenesis.
MIR30D has also been shown to be involved in the regulation of inflammation. It has been shown to be involved in the regulation of the transcription factor Nrf2, which is involved in the detoxification of environmental toxins. regulation of the transcription factor AP-1, which is involved in cell growth and apoptosis.
MIR30D as a Potential Drug Target
MIR30D has been shown to be involved in the regulation of cell proliferation, apoptosis, and angiogenesis, making it a potential drug target. drugs that target MIR30D may be effective in treating various diseases, including cancer.
MIR30D has been shown to be involved in the regulation of cell cycle progression. It has been shown to be involved in the regulation of the G1 phase and the S phase of the cell cycle. the G2 phase and the M phase of the cell cycle.
MIR30D has also been shown to be involved in the regulation of apoptosis. It has been shown to be involved in the regulation of apoptosis in various tissues, including brain, heart, and cancer. autophagy, which is a process that is involved in the breakdown of damaged or unnecessary cellular components.
MIR30D has also been shown to be involved in the regulation of angiogenesis. It has been shown to be involved in the regulation of angiogenesis in various tissues, including blood vessels, airways, and organs. of the production of new blood vessels, which is a critical step in the development of new tissues.
MIR30D as a Potential Biomarker
MIR30D has also been shown to be a potential biomarker for various diseases, including cancer. The expression of MIR30D has been shown to be associated with the development and progression of cancer. MIR30D has also been shown to be involved in the regulation of the detoxification of environmental toxins, which may be involved in the development of cancer.
MIR30D has also been shown to be involved in
Protein Name: MicroRNA 30d
The "MIR30D Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR30D comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178 | MIR3179-1 | MIR3179-2 | MIR3179-3 | MIR3180-1 | MIR3180-2 | MIR3180-3 | MIR3180-4 | MIR3180-5 | MIR3182 | MIR3183 | MIR3184 | MIR3185 | MIR3186 | MIR3187 | MIR3188 | MIR3189 | MIR3190
